Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition

Responding to a convergence of a changing market and shifts in technology, pharmaceutical companies are exploring ways to enhance the value of their products and find new opportunities beyond their core molecule-driven businesses.

By Wendy Diller

Pharma is having a Scylla and Charybdis moment. The relentless onslaught of patent expiries means cheap generics are available, even...

More from Archive

More from In Vivo